Exploring the space of histidine containing dipeptides in search of novel efficient RCS sequestering agents

European Journal of Medicinal Chemistry

Volumn 66, Issue , 2013, Pages 153-160

  Vistoli, Giulio ^a   De Maddis, Danilo ^a   Straniero, Valentina ^a   Pedretti, Alessandro ^a   Pallavicini, Marco ^a   Valoti, Ermanno ^a   Carini, Marina ^a   Testa, Bernard ^b   Aldini, Giancarlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

4 Hydroxy 2 nonenal; Carbonyl scavengers; Carnosine; Diastereoisomeric dipeptides; Histidine nucleophilicity; Reactive carbonyl species

Indexed keywords

4 HYDROXYNONENAL; AMIDE; CARBONYL DERIVATIVE; CARBOXYL GROUP; CARNOSINE; DIPEPTIDE; ESTER DERIVATIVE; GLYCINE; HISTIDINE; PYRIDOXAL; SEQUESTERING AGENT;

AEROBIC METABOLISM; ARTICLE; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DIASTEREOISOMER; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INCUBATION TIME; MICHAEL ADDITION; MOLECULAR MODEL; NUCLEOPHILICITY; PROTEIN CARBONYLATION; PROTEIN CONFORMATION; PROTEIN DEGRADATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STEREOSPECIFICITY; ULTRAVIOLET SPECTROSCOPY; LIPOPHILICITY;

EID: 84879221989     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2013.05.009     Document Type: Article

References (48)

1. S.J. Cho, G. Roman, F. Yeboah, Y. Konishi, The road to advanced glycation end products: a mechanistic perspective, Curr. Med. Chem. 14 (2007) 1653-1671. (Pubitemid 47010154)
2. E. Niki, Lipid peroxidation: physiological levels and dual biological effects, Free Radic. Biol. Med. 47 (2009) 469-484.
3. A.G. Madian, F.E. Regnier, Proteomic identification of carbonylated proteins and their oxidation sites, J. Proteome Res. 9 (2010) 3766-3780.
4. R. Pamplona, Advanced lipoxidation end-products, Chem. Biol. Interact. 192 (2011) 14-20.
5. M.C. Thomas, Advanced glycation end products, Contrib. Nephrol. 170 (2011) 66-74.
6. I. Dalle-Donne, G. Aldini, M. Carini, R. Colombo, R. Rossi, A. Milzani, Protein carbonylation, cellular dysfunction, and disease progression, J. Cell. Mol. Med. 10 (2006) 389-406. (Pubitemid 44870187)
7. T. Näsström, T. Fagerqvist, M. Barbu, M. Karlsson, F. Nikolajeff, A. Kasrayan, M. Ekberg, L. Lannfelt, M. Ingelsson, J. Bergström, The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties, Free Radic. Biol. Med. 50 (2011) 428-437.
8. G. Virella, S.R. Thorpe, N.L. Alderson, E.M. Stephan, D. Atchley, F. Wagner, M.F. Lopes-Virella, DCCT/EDIC Research Group, Autoimmune response to advanced glycosylation end-products of human LDL, J. Lipid Res. 44 (2003) 487-493. (Pubitemid 37279696)
9. D.P. Barlovic, A. Soro-Paavonen, K.A. Jandeleit-Dahm, RAGE biology, atherosclerosis and diabetes, Clin. Sci. (Lond.) 121 (2011) 43-55.
10. I. Dalle-Donne, D. Giustarini, R. Colombo, R. Rossi, A. Milzani, Protein carbonylation in human diseases, Trends Mol. Med. 9 (2003) 169-176. (Pubitemid 36626706)
11. G. Aldini, I. Dalle-Donne, R. Colombo, R. Maffei Facino, A. Milzani, M. Carini, Lipoxidation-derived reactive carbonyl species as potential drug targets in preventing protein carbonylation and related cellular dysfunction, Chem. Med. Chem. 1 (2006) 1045-1058. (Pubitemid 44622243)
12. G. Aldini, I. Dalle-Donne, R.M. Facino, A. Milzani, M. Carini, Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls, Med. Res. Rev. 27 (2007) 817-868. (Pubitemid 350035121)
13. G. Aldini, R.M. Facino, G. Beretta, M. Carini, Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therapeutic perspectives, Biofactors 24 (2005) 77-87. (Pubitemid 41750529)
14. A.R. Hipkiss, Carnosine and its possible roles in nutrition and health, Adv. Food Nutr. Res. 57 (2009) 87-154.
15. E.D. Pepper, M.J. Farrell, G. Nord, S.E. Finkel, Antiglycation effects of carnosine and other compounds on the long-term survival of Escherichia coli, Appl. Environ. Microbiol. 76 (2010) 7925-7930.
16. J. Pietkiewicz, A. Bronowicka-Szydełko, K. Dzierzba, R. Danielewicz, A. Gamian, Glycation of the muscle-specific enolase by reactive carbonyls: effect of temperature and the protection role of carnosine, pyridoxamine and phosphatidylserine, Protein J. 30 (2011) 149-158.
17. G. Aldini, M. Carini, G. Beretta, S. Bradamante, R.M. Facino, Carnosine is a quencher of 4-hydroxy-nonenal: through what mechanism of reaction? Biochem. Biophys. Res. Commun. 298 (2002) 699-706. (Pubitemid 35356796)
18. Y. Liu, G. Xu, L.M. Sayre, Carnosine inhibits (E)-4-hydroxy-2-nonenal- induced protein cross-linking: structural characterization of carnosine-HNE adducts, Chem. Res. Toxicol. 16 (2003) 1589-1597. (Pubitemid 38049378)
19. G. Aldini, M. Orioli, M. Carini, R. Maffei Facino, Profiling histidine-containing dipeptides in rat tissues by liquid chromatography/ electrospray ionization tandem mass spectrometry, J. Mass Spectrom. 39 (2004) 1417-1428. (Pubitemid 39664926)
20. S. Geissler, M. Zwarg, I. Knütter, F. Markwardt, M. Brandsch, The bioactive dipeptide anserine is transported by human proton-coupled peptide transporters, FEBS J. 277 (2010) 790-795.
21. A. Pegova, H. Abe, A. Boldyrev, Hydrolysis of carnosine and related compounds by mammalian carnosinases, Comp. Biochem. Physiol. B Biochem. Mol. Biol. 127 (2000) 443-446.
22. G. Vistoli, M. Carini, G. Aldini, Transforming dietary peptides in promising lead compounds: the case of bioavailable carnosine analogues, Amino Acids 17 (2012) 549-560.
23. G. Vistoli, A. Pedretti, M. Cattaneo, G. Aldini, B. Testa, Homology modeling of human serum carnosinase, a potential medicinal target, and MD simulations of its allosteric activation by citrate, J. Med. Chem. 49 (2006) 3269-3277. (Pubitemid 43830524)
24. A. Pedretti, L. De Luca, C. Marconi, G. Negrisoli, G. Aldini, G. Vistoli, Modeling of the intestinal peptide transporter hPepT1 and analysis of its transport capacities by docking and pharmacophore mapping, Chem. Med. Chem. 3 (2008) 1913-1921.
25. A. Pedretti, L. De Luca, C. Marconi, L. Regazzoni, G. Aldini, G. Vistoli, Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping, Bioorg. Med. Chem. 19 (2011) 4544-4551.
26. M. Werle, A. Bernkop-Schnürch, Strategies to improve plasma half life time of peptide and protein drugs, Amino Acids 30 (2006) 351-367. (Pubitemid 43886897)
27. G. Aldini, M. Orioli, G. Rossoni, F. Savi, P. Braidotti, G. Vistoli, K.J. Yeum, G. Negrisoli, M. Carini, The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats, J. Cell. Mol. Med. 15 (2011) 1339-1354.
28. M. Orioli, G. Vistoli, L. Regazzoni, A. Pedretti, A. Lapolla, G. Rossoni, R. Canevotti, L. Gamberoni, M. Previtali, M. Carini, G. Aldini, Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability, Chem. Med. Chem. 6 (2011) 1269-1282.
29. M. Bertinaria, B. Rolando, M. Giorgis, G. Montanaro, S. Guglielmo, M.F. Buonsanti, V. Carabelli, D. Gavello, P.G. Daniele, R. Fruttero, A. Gasco, Synthesis, physicochemical characterization, and biological activities of new carnosine derivatives stable in human serum as potential neuroprotective agents, J. Med. Chem. 54 (2011) 611-621.
30. F.I. Zuniga, D. Loi, K.H. Ling, D.D. Tang-Liu, Idiosyncratic reactions and metabolism of sulfur-containing drugs, Expert Opin. Drug Metab. Toxicol. 8 (2012) 467-485.
31. P. Di Simplicio, S. Frosali, R. Priora, D. Summa, F. Cherubini Di Simplicio, D. Di Giuseppe, A. Di Stefano, Biochemical and biological aspects of protein thiolation in cells and plasma, Antioxid. Redox Signal. 7 (2005) 951-963. (Pubitemid 40967146)
32. A. Elsheikh, S.N. Lavergne, J.L. Castrejon, J. Farrell, H. Wang, J. Sathish, W.J. Pichler, B.K. Park, D.J. Naisbitt, Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism, J. Immunol. 185 (2010) 6448-6460.
33. U. Rychlewska, B. Warzajtis, B.D. Glisić, M.D. Zivković, S. Rajković, M.I. Djuran, Monocationic gold(III) Gly-L-His and L-Ala-L-His dipeptide complexes: crystal structures arising from solvent free and solvent-containing crystal formation and structural modifications tuned by counter-anions, Dalton Trans. 39 (2010) 8906-8913.
34. A. Reis, C. Fonseca, E. Maciel, P. Domingues, M.R. Domingues, Influence of amino acid relative position on the oxidative modification of histidine and glycine peptides, Anal. Bioanal. Chem. 399 (2011) 2779-2794.
35. G. Beretta, R. Artali, L. Regazzoni, M. Panigati, R.M. Facino, Glycyl-histidyl-lysine (GHK) is a quencher of alpha, beta-4-hydroxy-trans-2- nonenal: a comparison with carnosine. insights into the mechanism of reaction by electrospray ionization mass spectrometry, 1H NMR, and computational techniques, Chem. Res. Toxicol. 20 (2007) 1309-1314. (Pubitemid 47548298)
36. G. Vistoli, M. Orioli, A. Pedretti, L. Regazzoni, R. Canevotti, G. Negrisoli, M. Carini, G. Aldini, Design, synthesis, and evaluation of carnosine derivatives as selective and efficient sequestering agents of cytotoxic reactive carbonyl species, Chem. Med. Chem. 4 (2009) 967-975.
37. A. Guiotto, A. Calderan, P. Ruzza, A. Osler, C. Rubini, D.G. Jo, M.P. Mattson, G. Borin, Synthesis and evaluation of neuroprotective alpha, beta-unsaturated aldehyde scavenger histidyl-containing analogues of carnosine, J. Med. Chem. 48 (2005) 6156-6161. (Pubitemid 41324622)
38. W.H. James 3rd, C.W. Müller, E.G. Buchanan, M.G. Nix, L. Guo, L. Roskop, M.S. Gordon, L.V. Slipchenko, S.H. Gellman, T.S. Zwier, Intramolecular amide stacking and its competition with hydrogen bonding in a small foldamer, J. Am. Chem. Soc. 131 (2009) 14243-14245.
39. G. Vistoli, V. Straniero, P. Pedretti, L. Fumagalli, C. Bolchi, M. Pallavicini, E. Valoti, B. Testa, Predicting the physicochemical profile of diastereoisomeric histidine-containing dipeptides by property space analysis, Chirality 24 (2012) 566-576.
40. Y. Zyrianov, Distribution-based descriptors of the molecular shape, J. Chem. Inf. Model. 45 (2005) 657-672. (Pubitemid 40795170)
41. D.E. Clark, What has polar surface area ever done for drug discovery? Future Med. Chem. 3 (2011) 469-484.
42. P. Gaillard, P.A. Carrupt, B. Testa, A. Boudon, Molecular lipophilicity potential, a tool in 3D-QSAR. Method and applications, J. Comput. Aided Mol. Des. 8 (1994) 83-96.
43. G. Vistoli, A. Pedretti, B. Testa, Chemodiversity and molecular plasticity: recognition processes as explored by property spaces, Future Med. Chem. 3 (2011) 995-1010.
44. Z. Wang, S. Watanabe, Y. Kobayashi, M. Tanaka, T. Matsui, Trp-His, a vaso-relaxant di-peptide, can inhibit extracellular Ca2+ entry to rat vascular smooth muscle cells through blockade of dihydropyridine-like L-type Ca2+ channels, Peptides 31 (2010) 2060-2066.
45. S. Menini, C. Iacobini, C. Ricci, A. Scipioni, C.B. Fantauzzi, A. Giaccari, E. Salomone, R. Canevotti, A. Lapolla, M. Orioli, G. Aldini, G. Pugliese, D-carnosine-octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation, Br. J. Pharmacol. 166 (2012) 1344-1356.
46. T. Taguchi, M. Sugiura, Y. Hamada, I. Miwa, Inhibition of advanced protein glycation by a Schiff base between aminoguanidine and pyridoxal, Eur. J. Pharmacol. 378 (1999) 283-289. (Pubitemid 29392929)
47. A. Pedretti, L. Villa, G. Vistoli, VEGA: a versatile program to convert, handle and visualize molecular structure on windows-based PCs, J. Mol. Graph. 21 (2002) 47-49. (Pubitemid 34628493)
48. G. Vistoli, A. Pedretti, B. Testa, Partition coefficient and molecular flexibility: the concept of lipophilicity space, Chem. Biodivers. 6 (2009) 1152-1169.